Stalevo

Medicinal product

(Invented) name

Stalevo

Active substance (s)

Levodopa/Karbidopa/Entakaponas

Strength

150 mg/37,5 mg/200 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

N04BA03, Levodopa, decarboxylase inhibitor and COMT inhibitor

Marketing authorisation holder

Orion Corporation, Suomija

Date of authorisation

2003-10-17

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
28336	30862	1030862	buteliukas	N10	Receptinis	EU/1/03/260/009	Netiekiama	-	-	No	-	-
28337	5017	1005017	buteliukas	N30	Receptinis	EU/1/03/260/010	Netiekiama	-	-	No	-	-
28338	4405	1004405	buteliukas	N100	Receptinis	EU/1/03/260/011	Tiekiama	-	-	No	-	-
28339	30863	1030863	buteliukas	N250	Receptinis	EU/1/03/260/012	Netiekiama	-	-	No	-	-
28340	30864	1030864	buteliukas	N175	Receptinis	EU/1/03/260/015	Netiekiama	-	-	No	-	-
28341	30865	1030865	buteliukas	N130	Receptinis	EU/1/03/260/018	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2003-10-17	Registruotas